Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran Vaccines in the United States

NCT06130345 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT06130345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran Vaccines in the United States
Lead sponsor
ModernaTX, Inc.
Phase
Observational
Overall status
Completed
Start date
April 14, 2023
Completion date
August 31, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2